Home Antibody All anti-RBM15 antibodies
Anti-RBM15 GAT Antibody Polyclonal
Generated by Genomic Immunization
Also for RBM15 (NM_022768)
|DNA immunization. This antibody is specific for the Middle Region of the target protein.|
|WB, ELISA, IHC
||WB: 1:5000-1:20000; ELISA: 1:100-1:2000
|20 mM Potassium Phosphate, 150 mM Sodium Chloride, pH 7.0|
|The fragment used for DNA immunization was expressed in E.coli and the purified protein fragment was used for affinity purification of the antibody.
|This antibody was generated by SDIX's Genomic Antibody Technology ® (GAT). Learn about GAT
|Homo sapiens RNA binding motif protein 15 (RBM15), transcript variant 1|
|OTT; OTT1; SPEN|
Entrez Gene 64783 Human
|Members of the SPEN (Split-end) family of proteins, including RBM15, have repressor function in several signaling pathways and may bind to RNA through interaction with spliceosome components (Hiriart et al., 2005 [PubMed 16129689]).[supplied by OMIM]|
|Transcription Factors |
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western Blot: RBM15 Antibody - Samples: Lane 1: Marker: 250, 130, 95, 72, 55, 36, 28, 17, 11 / Lane 2: RT-4 / Lane 3: U-251MG sp / Lane 4: Human Plasma / Lane 5: Liver / Lane 6: Tonsil; Target weight: 107, 106, 3 (splice variants)
Immunohistochemistry: RBM15 Antibody - A majority of normal and malignant tissues showed moderate to strong nuclear and moderate cytoplasmic staining. In normal tissues, strongest positivity was found in gastro-intestinal glandular cells and in neuronal cells of the CNS. Prostate, bile duct cells and ovarian stromal cells were negative. Malignant tissues stained similarly, with strongest immunoreactivity found in colo-rectal cancers and malignant gliomas. Other tumors generally displayed moderate nuclear and cytoplasmic staining. Most prostate cancers were negative. Image and statement courtesy of the Human Protein Atlas (HPA).